Glucosamine exhibits a protective action on joint disorders accompanying pain and loss of motion, based on its anti-inflammatory action. We have revealed that glucosamine downregulates the expression of IL-8 gene via
O-linked-N-acetylglucosamine (
O-GlcNAc) modification, a post translational modification of proteins involved in the modulation of several cellular functions. Importantly, the transcription factor NF-κB (p65/p50 heterodimer) regulates the production of proinflammatory molecules. Thus, in this study, we investigated the effect of glucosamine on the activation of NF-κB, and the role of
O-GlcNAc modification in NF-κB activation using a synovial cells line MH7A.
Glucosamine inhibited the IL-1β-induced phosphorylation and nuclear translocation of NF-κB p65 subunit. Glucosamine also inhibited the IL-1β-induced dissociation of IκBα (the NF-κB inhibiting protein) from NF-κB. Importantly, alloxan, an
O-GlcNAc transferase inhibitor, which inhibits
O-GlcNAc modification, abolished the glucosamine-mediated inhibition of the phosphorylation, translocation of NF-κB and dissociation of IκBα.
Together these observations suggest that glucosamine suppresses the activation of NF-κB (phosphorylation and nuclear translocation) by the inhibition of IκBα dissociation from NF-κB via
O-GlcNAc modification.
View full abstract